论文信息 - One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model - 字舞流文

One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model

F. Gleeson | M. Carroll | H. Humphries | Trevor R. F. Smith | S. Ramos | K. Schultheis | L. Humeau | K. Broderick | S. Charlton | F. Salguero | E. Rayner | S. Fotheringham | Robert J. Watson | L. Sibley | C. Sarfas | M. Dennis | S. Sharpe | K. Gooch | Y. Hall | G. Slack | S. Longet | A. White | T. Tipton | A. Handley | K. Ryan | T. Smith | Alastair Handley | Gillian S. Slack